aTyr Pharma, Inc.ATYRNASDAQ
Loading
Year-over-year debt growth rate
| Period | Value |
|---|---|
| Q4 2025 | -2.64% |
| Q3 2025 | -2.52% |
| Q2 2025 | -2.40% |
| Q1 2025 | -2.21% |
| Q4 2024 | -2.11% |
| Q3 2024 | -2.03% |
| Q2 2024 | -1.95% |
| Q1 2024 | -6.42% |
| Q4 2023 | -0.81% |
| Q3 2023 | -1.12% |
| Q2 2023 | 7.73% |
| Q1 2023 | 23.87% |
| Q4 2022 | 33.33% |
| Q3 2022 | 579.04% |
| Q2 2022 | 11.27% |
| Q1 2022 | -16.91% |
| Q4 2021 | -14.20% |
| Q3 2021 | -12.00% |
| Q2 2021 | -10.32% |
| Q1 2021 | -9.11% |
| Q4 2020 | -59.29% |
| Q3 2020 | -27.71% |
| Q2 2020 | -21.41% |
| Q1 2020 | -17.48% |
| Q4 2019 | -14.71% |
| Q3 2019 | -12.70% |
| Q2 2019 | -11.13% |
| Q1 2019 | 10.59% |
| Q4 2018 | -9.98% |
| Q3 2018 | -8.99% |
| Q2 2018 | -2.06% |
| Q1 2018 | 1.25% |
| Q4 2017 | 33.81% |
| Q3 2017 | 1.15% |
| Q2 2017 | 52.27% |
| Q1 2017 | 0.39% |
| Q4 2016 | 261.25% |
| Q3 2016 | -24.33% |
| Q2 2016 | -19.29% |
| Q1 2016 | -15.93% |